Lars Hillringhaus

Title: Lars Hillringhaus: Innovator in Binding Agents and Assays

Introduction

Lars Hillringhaus is a notable inventor based in Munich, Germany. He has made significant contributions to the field of diagnostics through his innovative patents. With a total of three patents to his name, Hillringhaus has focused on developing specific binding agents and assays that enhance detection methods in medical applications.

Latest Patents

Hillringhaus's latest patents include a binding agent and assay for PIVKA. This invention relates to specific binding agents that bind to different PIVKA-II forms, offering a novel approach compared to existing antibodies. The patent also outlines methods for using these binding agents to detect the presence of PIVKA-II in various samples. Another significant patent is for a biotin-specific monoclonal antibody. This antibody is capable of binding to biotin while ensuring it does not bind to a biotin moiety on a biotinylated molecule. The invention includes a method for generating this antibody, which is particularly useful in measuring analytes in samples using a (strept)avidin/biotin pair.

Career Highlights

Lars Hillringhaus is currently employed at Roche Diagnostics Operations, Inc., where he continues to innovate in the field of diagnostics. His work has contributed to advancements in medical testing and analysis, making a positive impact on healthcare.

Collaborations

Hillringhaus has collaborated with notable colleagues, including Michael Gerg and Klaus Hirzel. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in diagnostics.

Conclusion

Lars Hillringhaus is a distinguished inventor whose work in binding agents and assays has advanced the field of diagnostics. His contributions are vital for improving detection methods in medical applications, showcasing the importance of innovation in healthcare.